G-protein coupled receptors (GPCRs) represent the largest and most therapeutically important family of cell surface receptors, mediating the effects of approximately 40% of all marketed drugs. These receptors respond to a remarkably diverse array of ligands including neurotransmitters, hormones, chemokines, and sensory stimuli. Understanding GPCR structure and signaling pathways is fundamental to comprehending drug action across virtually all therapeutic areas from cardiovascular medicine to psychiatry.
GPCR Structure
GPCRs share a common structural architecture characterized by seven transmembrane domains that span the cell membrane seven times, forming three extracellular loops and three intracellular loops. The extracellular N-terminus and extracellular loops typically contribute to ligand binding, while the intracellular C-terminus and third intracellular loop mediate interactions with G-proteins and other signaling molecules. Despite this conserved structure, GPCRs exhibit remarkable diversity in their ligand recognition properties and signaling mechanisms.
When a ligand binds to the extracellular domain of a GPCR, it induces a conformational change that is transmitted through the transmembrane helices to the intracellular surface. This conformational change allows the receptor to interact with and activate heterotrimeric G-proteins located on the inner surface of the cell membrane. The ability of a single receptor to activate multiple G-protein molecules creates signal amplification, allowing even low concentrations of ligand to produce substantial cellular responses. Following activation, GPCRs are typically desensitized through phosphorylation by G-protein receptor kinases (GRKs) and binding of arrestin proteins, which uncouple the receptor from G-proteins and may initiate alternative signaling pathways.
G-Protein Subtypes and Effector Systems
Heterotrimeric G-proteins consist of three subunits: alpha (α), beta (β), and gamma (γ). In the inactive state, the α-subunit is bound to guanosine diphosphate (GDP). Upon receptor activation, GDP is exchanged for guanosine triphosphate (GTP), causing the G-protein to dissociate into an α-subunit-GTP complex and a βγ-dimer. Both the activated α-subunit and the βγ-dimer can regulate effector molecules, initiating downstream signaling cascades. There are four major classes of Gα subunits, each coupling receptors to distinct effector systems: Gs, Gi, Gq, and G12/13.
Gs (stimulatory G-protein) activates adenylyl cyclase, an enzyme that converts ATP to the second messenger cyclic AMP (cAMP). Increased cAMP levels activate protein kinase A (PKA), which phosphorylates various intracellular proteins to produce cellular responses. Beta-adrenoceptors are classic examples of Gs-coupled receptors. When norepinephrine or epinephrine binds to beta-1 adrenoceptors in cardiac myocytes, Gs-mediated adenylyl cyclase activation increases cAMP, leading to PKA-mediated phosphorylation of calcium channels and contractile proteins, ultimately increasing heart rate and contractility.
Gi (inhibitory G-protein) inhibits adenylyl cyclase, reducing cAMP production, and may also directly regulate ion channels. Opioid receptors are Gi-coupled receptors that mediate analgesia, respiratory depression, and euphoria. When morphine binds to mu-opioid receptors, Gi activation reduces adenylyl cyclase activity, closes voltage-gated calcium channels, and opens G-protein coupled inwardly rectifying potassium (GIRK) channels. These effects collectively reduce neuronal excitability and neurotransmitter release, producing analgesia by inhibiting pain signaling pathways in the central nervous system.
Gq activates phospholipase C-β (PLC-β), which cleaves the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) into two second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 binds to receptors on the endoplasmic reticulum, causing release of stored calcium ions into the cytoplasm. DAG, remaining in the membrane, activates protein kinase C (PKC), which phosphorylates various target proteins. Alpha-1 adrenoceptors, histamine H1 receptors, and serotonin 5-HT2A receptors are examples of Gq-coupled receptors that mediate diverse physiological responses including smooth muscle contraction, glandular secretion, and neuronal excitation.
Second Messengers and Downstream Effects
The second messengers generated by GPCR activation—cAMP, IP3, DAG, and calcium ions—serve as intracellular signaling molecules that amplify and propagate the signal initiated by receptor activation. These molecules regulate a vast array of cellular processes through activation of protein kinases, modulation of ion channel activity, and regulation of gene expression. The specific cellular response depends on the cell type, the particular G-proteins activated, and the complement of effector molecules and transcription factors expressed by that cell.
GPCR signaling is subject to extensive feedback regulation and desensitization mechanisms that prevent excessive or prolonged stimulation. Following activation, Gα-subunits possess intrinsic GTPase activity that hydrolyzes GTP to GDP, allowing the subunits to reassociate with βγ-dimers and return to the inactive state. Additional regulatory mechanisms include receptor phosphorylation by GRKs and second messenger-activated kinases, arrestin binding leading to desensitization and internalization, and regulation of second messenger concentrations by phosphodiesterases that degrade cAMP and cGMP. These regulatory processes ensure that GPCR signaling is appropriately controlled both temporally and spatially.
